BDE-99 impairs differentiation of human and mouse NPCs into the oligodendroglial lineage by species-specific modes of action

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Dach, Katharina ^a   Bendt, Farina ^a   Huebenthal, Ulrike ^a   Giersiefer, Susanne ^a   Lein, Pamela J ^b   Heuer, Heike ^a   Fritsche, Ellen ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2',4,4',5-BROMINATED DIPHENYL ETHER; CKAP5 PROTEIN, MOUSE; DIPHENYL ETHER DERIVATIVE; MICROTUBULE ASSOCIATED PROTEIN; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE;

ANIMAL; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MOUSE; NEURAL STEM CELL; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; HALOGENATED DIPHENYL ETHERS; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NEURAL STEM CELLS; OLIGODENDROGLIA; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TYROSINE 3-MONOOXYGENASE;

EID: 85015747832     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep44861     Document Type: Article

References (79)

1. Law, R. J., et al. Levels and trends of PBDEs and HBCDs in the global environment: Status at the end of 2012. Environ. Int. 65, 147-158 (2014).
2. Ma, Y., Salamova, A., Venier, M., & Hites, R. A. Has the Phase-Out of PBDEs Affected Their Atmospheric Levels? Trends of PBDEs and Their Replacements in the Great Lakes Atmosphere. Environ. Sci. Technol. 47, 11457-11464 (2013).
3. Shaw, S. D., & Kannan, K. Polybrominated diphenyl ethers in marine ecosystems of the American continents: foresight from current knowledge. Rev. Environ. Health 24, 157-229 (2009).
4. Yogui, G. T., & Sericano, J. L. Polybrominated diphenyl ether flame retardants in the U.S. marine environment: a review. Environ. Int. 35, 655-66 (2009).
5. Frederiksen, M., Vorkamp, K., Thomsen, M., & Knudsen, L. E. Human inteRNAl and exteRNAl exposure to PBDEs-A review of levels and sources. Int. J. Hyg. Environ. Health 212, 109-34 (2009).
6. Sjödin, A., Patterson, D. G., & Bergman, A. A review on human exposure to brominated flame retardants-particularly polybrominated diphenyl ethers. Environ. Int. 29, 829-39 (2003).
7. Fischer, D., Hooper, K., Athanasiadou, M., Athanassiadis, I., & Bergman, A. Children Show Highest Levels of Polybrominated Diphenyl Ethers in a California Family of Four: A Case Study. Environ. Health Perspect. 114, 1581-1584 (2006).
8. Toms, L.-M. L., et al. Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2-5 years of age) than in infants and adults. Environ. Health Perspect. 117, 1461-5 (2009).
9. Rose, M., et al. PBDEs in 2-5 year-old children from California and associations with diet and indoor environment. Environ. Sci. Technol. 44, 2648-53 (2010).
10. Grandjean, P., & Landrigan, P. J. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 13, 330-8 (2014).
11. Eskenazi, B., et al. In Utero and Childhood Polybrominated Diphenyl Ether (PBDE) Exposures and Neurodevelopment in the CHAMACOS Study. Env. Heal. Perspect 121, 257-262 (2013).
12. Roze, E., et al. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ. Health Perspect. 117, 1953-8 (2009).
13. Herbstman, J. B., et al. Prenatal exposure to PBDEs and neurodevelopment. Environ. Health Perspect. 118, 712-9 (2010).
14. BeRNAl, J. Thyroid hormones and brain development. Vitam. Horm. 71, 95-122 (2005).
15. Namba, N., et al. Clinical phenotype and endocrinological investigations in a patient with a mutation in the MCT8 thyroid hormone transporter. Eur. J. Pediatr. 167, 785-91 (2008).
16. Rodrigues, F., et al. Hypotonic male infant and MCT8 deficiency - a diagnosis to think about. BMC Pediatr. 14, 252 (2014).
17. Marta, C. B., Adamo, A. M., Soto, E. F., & Pasquini, J. M. Sustained neonatal hyperthyroidism in the rat affects myelination in the central nervous system. J. Neurosci. Res. 53, 251-9 (1998).
18. Rodriguez-Peña, A., Ibarrola, N., Iñiguez, M. A., Muñoz, A., & BeRNAl, J. Neonatal hypothyroidism affects the timely expression of myelin-Associated glycoprotein in the rat brain. J. Clin. Invest. 91, 812-8 (1993).
19. Baumann, N., & Pham-Dinh, D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871-927 (2001).
20. Nave, K.-A. Myelination and support of axonal integrity by glia. Nature 468, 244-252 (2010).
21. Fields, R. D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31, 361-70 (2008).
22. Kodavanti, P. R. S., et al. Developmental exposure to a commercial PBDE mixture, DE-71: neurobehavioral, hormonal, and reproductive effects. Toxicol. Sci. 116, 297-312 (2010).
23. Zhou, T., Taylor, M. M., DeVito, M. J., & Crofton, K. M. Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption. Toxicol. Sci. 66, 105-16 (2002).
24. Branchi, I., Alleva, E., & Costa, L. G. Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development. Neurotoxicology 23, 375-84 (2002).
25. Dufault, C., Poles, G., & Driscoll, L. L. Brief postnatal PBDE exposure alters learning and the cholinergic modulation of attention in rats. Toxicol. Sci. 88, 172-80 (2005).
26. Eriksson, P., Viberg, H., Jakobssonm, E., Örn, U., & Frederiksson, A. A Brominated Flame Retardant, 2, 2?, 4, 4?, 5-Pentabromodiphenyl Ether: Uptake, Retention, and Induction of Neurobehavioral Alterations in Mice during a Critical Phase of Neonatal Brain Development. Toxicol. Sci. 67, 98-103 (2002).
27. Negishi, T., et al. Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats. Behav. Brain Res. 159, 323-31 (2005).
28. Herbstman, J. B., et al. Birth Delivery Mode Modifies the Associations between Prenatal Polychlorinated Biphenyl (PCB) and Polybrominated Diphenyl Ether (PBDE) and Neonatal Thyroid Hormone Levels. Environ. Health Perspect. 116, 1376-1382 (2008).
29. Stapleton, H. M., Eagle, S., Anthopolos, R., Wolkin, A., & Miranda, M. L. Associations between Polybrominated Diphenyl Ether (PBDE) Flame Retardants, Phenolic Metabolites, and Thyroid Hormones during Pregnancy. Env. Heal. Perspect 119, 1454-9 (2011).
30. Chevrier, J., et al. Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy. Environ. Health Perspect. 118, 1444-9 (2010).
31. Zota, A. R., et al. Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in California. Environ. Sci. Technol. 45, 7896-905 (2011).
32. Schreiber, T., et al. Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ. Health Perspect. 118, 572-8 (2010).
33. Baumann, J., et al. Application of the Neurosphere Assay for DNT Hazard Assessment: Challenges and Limitations. Methods Pharmacol. Toxicol. 1-29 (2016).
34. Barenys, M., et al. Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro. Arch. Toxicol. (2016).
35. Ongr, D., Drevets, W. C., & Price, J. L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 95, 13290-5 (1998).
36. Stark, A. K., Uylings, H. B. M., Sanz-Arigita, E., & Pakkenberg, B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am. J. Psychiatry 161, 882-8 (2004).
37. Irintchev, A., Rollenhagen, A., Troncoso, E., Kiss, J. Z., & Schachner, M. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. Cereb. Cortex 15, 950-62 (2005).
38. Jakovcevski, I., et al. Close homologue of adhesion molecule L1 promotes survival of Purkinje and granule cells and granule cell migration during murine cerebellar development. J. Comp. Neurol. 513, 496-510 (2009).
39. Chen, C., et al. Thyroid hormone promotes neuronal differentiation of embryonic neural stem cells by inhibiting STAT3 signaling through TRa 1. Stem Cells Dev. 21, 2667-81 (2012).
40. López-Juárez, A., et al. Thyroid hormone signaling acts as a neurogenic switch by repressing Sox2 in the adult neural stem cell niche. Cell Stem Cell 10, 531-43 (2012).
41. Bradley, D. J., Towle, H. C., & Young, W. S. Spatial and temporal expression of alpha- and beta-Thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J. Neurosci. 12, 2288-2302 (1992).
42. Thompson, C. C., & Potter, G. B. Thyroid hormone action in neural development. Cereb. Cortex 10, 939-45 (2000).
43. Potter, G. B., Zarach, J. M., Sisk, J. M., & Thompson, C. C. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol. Endocrinol. 16, 2547-60 (2002).
44. Ramos, H. E., & Weiss, R. E. Regulation of nuclear coactivator and corepressor expression in mouse cerebellum by thyroid hormone. Thyroid 16, 211-6 (2006).
45. Hagen, G. A., & Elliott, W. J. Transport of thyroid hormones in serum and cerebrospinal fluid. J. Clin. Endocrinol. Metab. 37, 415-22 (1973).
46. Anckarsäter, R., Zetterberg, H., Blennow, K., & Anckarsäter, H. Association between thyroid hormone levels and monoaminergic neurotransmission during surgery. Psychoneuroendocrinology 32, 1138-43 (2007).
47. Nishikawa, M., et al. 3, 3', 5'-TrIIodothyronine (reverse T3) in human cerebrospinal fluid. J. Clin. Endocrinol. Metab. 53, 1030-5 (1981).
48. Johansson, P., et al. Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer?s disease. Psychoneuroendocrinology 38, 1058-66 (2013).
49. Costa, L. G., de Laat, R., Tagliaferri, S., & Pellacani, C. A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity. Toxicol. Lett. 282-294 (2014).
50. Ibarrola, N., & Rodríguez-Peña, A. Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development. Brain Res. 752, 285-93 (1997).
51. Schoonover, C. M., et al. Thyroid hormone regulates oligodendrocyte accumulation in developing rat brain white matter tracts. Endocrinology 145, 5013-20 (2004).
52. Farsetti, A., Mitsuhashi, T., Desvergne, B., Robbins, J., & Nikodem, V. M. Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J. Biol. Chem. 266, 23226-32 (1991).
53. Li, T., Wang, W., Pan, Y.-W., Xu, L., & Xia, Z. A hydroxylated metabolite of flame-retardant PBDE-47 decreases the survival, proliferation, and neuronal differentiation of primary cultured adult neural stem cells and interferes with signaling of ERK5 MAP kinase and neurotrophin 3. Toxicol. Sci. 134, 111-24 (2013).
54. Costa, L. G., & Giordano, G. Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology 28, 1047-67 (2007).
55. Schecter, A., et al. Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ. Health Perspect. 114, 1515-20 (2006).
56. Voorspoels, S., Covaci, A., Lepom, P., Jaspers, V. L. B., & Schepens, P. Levels and distribution of polybrominated diphenyl ethers in various tissues of birds of prey. Environ. Pollut. 144, 218-27 (2006).
57. Ta, T. A., et al. Bioaccumulation and behavioral effects of 2, 2?, 4, 4?-Tetrabromodiphenyl ether (BDE-47) in perinatally exposed mice. Neurotoxicol. Teratol. 33, 393-404 (2011).
58. Baxi, E. G., et al. A selective thyroid hormone receptor agonist enhances human and rodent oligodendrocyte differentiation. Glia 62, 1513-1529 (2014).
59. Murray, K., & Dubois-Dalcq, M. Emergence of oligodendrocytes from human neural spheres. J. Neurosci. Res. 50, 146-56 (1997).
60. Barres, B., Lazar, M., & Raff, M. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120, 1097-1108 (1994).
61. Ibarrola, N., Mayer-Pröschel, M., Rodriguez-Peña, A., & Noble, M. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 180, 1-21 (1996).
62. Koper, J. W., Hoeben, R. C., Hochstenbach, F. M., van Golde, L. M., & Lopes-Cardozo, M. Effects of trIIodothyronine on the synthesis of sulfolipids by oligodendrocyte-enriched glial cultures. Biochim. Biophys. Acta 887, 327-34 (1986).
63. Billon, N., Jolicoeur, C., Tokumoto, Y., Vennström, B., & Raff, M. Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO J. 21, 6452-60 (2002).
64. Picou, F., Fauquier, T., Chatonnet, F., & Flamant, F. A bimodal influence of thyroid hormone on cerebellum oligodendrocyte differentiation. Mol. Endocrinol. 26, 608-18 (2012).
65. Tonduti, D., et al. MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features. J. Child Neurol. 28, 795-800 (2013).
66. López-Espíndola, D., et al. Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. J. Clin. Endocrinol. Metab. 99, E2799-804 (2014).
67. Barateiro, A., & Fernandes, A. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim. Biophys. Acta 1843, 1917-29 (2014).
68. Pinnell, S. R. Regulation of collagen biosynthesis by ascorbic acid: a review. Yale J. Biol. Med. 58, 553-9 (1985).
69. Carey, D. J., & Todd, M. S. Schwann cell myelination in a chemically defined medium: demonstration of a requirement for additives that promote Schwann cell extracellular matrix formation. Dev. Brain Res. 32, 95-102 (1987).
70. Eldridge, C. F., Bunge, M. B., Bunge, R. P., & Wood, P. M. Differentiation of Axon-related Schwann Cells In Vitro. I. Ascorbic Acid Regulates Basal Lamina Assembly and Myelin Formation. J. Cell Biol. 105, 1023-1034 (1987).
71. Podratz, J. L., Rodriguez, E. H., & Windebank, A. J. Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro. Glia 45, 54-8 (2004).
72. Moore, C. S., Abdullah, S. L., Brown, A., Arulpragasam, A., & Crocker, S. J. How factors secreted from astrocytes impact myelin repair. J. Neurosci. Res. 89, 13-21 (2011).
73. Condorelli, D. F., Dell'Albani, P., Mudo, G., Timmusk, T., & Belluardo, N. Expression of Neurotrophins and Their Receptors in Primary Astroglial Cultures: Induction by Cyclic AMP-Elevating Agents. J. Neurochem. 63, 509-516 (2002).
74. Rudge, J. S., et al. Expression of Ciliary Neurotrophic Factor and the Neurotrophins-Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Neurotrophin 3-in Cultured Rat Hippocampal Astrocytes. Eur. J. Neurosci. 4, 459-471 (1992).
75. Singh, L., et al. Chasing the Elusive Benzofuran Impurity of the THR Antagonist NH-3: Synthesis, Isotope Labeling, and Biological Activity. J. Org. Chem. 81, 1870-6 (2016).
76. Workman, A. D., Charvet, C. J., Clancy, B., Darlington, R. B., & Finlay, B. L. Modeling transformations of neurodevelopmental sequences across mammalian species. J. Neurosci. 33, 7368-83 (2013).
77. Baumann, J., Barenys, M., Gassmann, K., & Fritsche, E. Comparative human and rat ?neurosphere assay? for developmental neurotoxicity testing. Curr. Protoc. Toxicol. 59, 12.21.1-12.21.24 (2014).
78. Moors, M., et al. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 117, 1131-8 (2009).
79. Breier, J. M., et al. Neural progenitor cells as models for high-Throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 32, 4-15 (2010).